322 related articles for article (PubMed ID: 16767955)
1. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
2. The role of recombinant-activated factor VII in bleeding trauma patients.
Dutton RP; Conti BM
Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
[TBL] [Abstract][Full Text] [Related]
3. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
4. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
Martinowitz U; Kenet G; Segal E; Luboshitz J; Lubetsky A; Ingerslev J; Lynn M
J Trauma; 2001 Sep; 51(3):431-8; discussion 438-9. PubMed ID: 11535886
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII (rFVIIa, NovoSeven).
Agarwal MB; Patnaik M
J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
[TBL] [Abstract][Full Text] [Related]
7. Treatment of critical bleeding in trauma patients.
Chiara O; Cimbanassi S; Brioschi PR; Bucci L; Terzi V; Vesconi S
Minerva Anestesiol; 2006 Jun; 72(6):383-7. PubMed ID: 16682905
[TBL] [Abstract][Full Text] [Related]
8. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
9. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
[TBL] [Abstract][Full Text] [Related]
10. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
Mohr AM; Holcomb JB; Dutton RP; Duranteau J
Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
Benharash P; Bongard F; Putnam B
Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
Grounds M
Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
[TBL] [Abstract][Full Text] [Related]
14. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.
Vincent JL; Rossaint R; Riou B; Ozier Y; Zideman D; Spahn DR
Crit Care; 2006; 10(4):R120. PubMed ID: 16919168
[TBL] [Abstract][Full Text] [Related]
15. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
16. The use of recombinant activated factor VII in platelet-associated bleeding.
Franchini M; Lippi G; Guidi GC
Hematology; 2008 Feb; 13(1):41-5. PubMed ID: 18534065
[TBL] [Abstract][Full Text] [Related]
17. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
[TBL] [Abstract][Full Text] [Related]
18. Treatment of traumatic bleeding with recombinant factor VIIa.
Kenet G; Walden R; Eldad A; Martinowitz U
Lancet; 1999 Nov; 354(9193):1879. PubMed ID: 10584732
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
20. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]